logo-loader
viewSonavex

Sonavex to begin commercial roll-out of its blood clot detection device Q1 2019

Sonavex Inc CEO David Narrow sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco.

The Baltimore-based medical device company, has developed EchoSure, its first product in Sonavex’s portfolio of new technologies to receive FDA clearance, to detect blood clots after surgery to prevent surgical failures.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Ontario's cannabis retail expansion plan gives cannabis stocks...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, was 1.4% higher at 116.7 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF jumped 2.4% at C$9.55, while the OTCQX Cannabis index gained 0.6% to 434 points. Buds today are The Green...

1 day, 17 hours ago

2 min read